Study Involvement Is Not Conflict For Advisory Cmte Members – FDA’s Temple
Executive Summary
Conducting clinical trials for a manufacturer generally does not pose a conflict of interest risk for advisory committee members, FDA Office of Medical Policy Director Robert Temple said Aug. 23
You may also be interested in...
Advisory Panel Conflict Waivers To Stay; FDA Will Provide Clarity On Process
FDA's plan for improving its advisory committee member selection process focuses on increasing the transparency and consistency of the existing process rather than an overhaul of its practices
FDA Advisory Committee Conflict Policy Takes A Toll; Chairs Plan Response
Cardiovascular & Renal Drugs Advisory Committee Chair William Hiatt plans to write an editorial concerning the need for a more transparent conflict of interest policy for panel members
FDA Advisory Committee Conflict Policy Takes A Toll; Chairs Plan Response
Cardiovascular & Renal Drugs Advisory Committee Chair William Hiatt plans to write an editorial concerning the need for a more transparent conflict of interest policy for panel members